|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization of debt discounts and issuance costs | |||||
| Amortization of deferred commissions costs | |||||
| Asset impairments and lease abandonment charges | |||||
| Gain on lease modification | |||||
| Loss on debt modification and extinguishment | |||||
| Deferred consideration valuation adjustments | |||||
| Equity-based compensation expense | |||||
| Deferred income taxes | |||||
| Tax receivable agreement remeasurement | |||||
| Provision for bad debt expense | |||||
| Changes in operating assets and liabilities, net of acquisitions: | |||||
| Accounts receivable, net | |||||
| Prepaid expenses and other current assets | |||||
| Deferred costs and other assets, net of current portion | |||||
| Income tax receivable | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Unearned revenue | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of investments | |||||
| Maturities of investments | |||||
| Proceeds from sales of investments | |||||
| Purchases of property and equipment and other assets | |||||
| Right of use asset initial direct costs | |||||
| Cash paid for acquisitions, net of cash acquired | |||||
| Net cash (used in) provided by investing activities | |||||
| Financing activities: | |||||
| Payments of deferred consideration | |||||
| Proceeds from debt issuances | |||||
| Payments of debt issuance and modification costs | |||||
| Repayment of debt | |||||
| Proceeds from Long-Term Lines of Credit | |||||
| Proceeds from exercise of stock options | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Proceeds from issuance of common stock under the ESPP | |||||
| Payments of equity issuance costs | |||||
| Tax receivable agreement payments | |||||
| Repurchase of common stock | |||||
| Tax distributions | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of period | |||||
| Cash, cash equivalents, and restricted cash at end of period | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid in cash | |||||
| Cash paid for taxes | |||||
| Supplemental disclosures of non-cash investing and financing activities: | |||||
| Equity-based compensation included in capitalized software | |||||
| Property and equipment included in accounts payable and accrued expenses and other current liabilities | |||||
| Deferred variable consideration from acquisition of a business | |||||
| Cash, cash equivalents, and restricted cash at end of period: | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current | |||||
| Restricted cash, non-current | |||||
Loading...